Moderna's candidate COVID-19 vaccine looks to protect 94.5% of those who get it, trial shows. 'This makes me giddy,' one doctor says.
Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial
Pfizer and AstraZeneca slide as Moderna's rival COVID-19 vaccine shows strong efficacy
Moderna's COVID-19 vaccine can be stored in a normal refrigerator, unlike Pfizer's.
abcnews.go.com 0 12616 0 0 0